Bone metastases in hepatocellular carcinoma: an emerging issue

Area of Science:

• Oncology
• Bone Metastasis Research
• Hepatocellular Carcinoma Studies

Background:

• Bone metastases (BMs) in hepatocellular carcinoma (HCC) are historically underdiagnosed.
• Recent advances in imaging and multidisciplinary care have improved HCC progression management.
• Understanding HCC BMs is crucial for patient prognosis and treatment strategies.

Purpose of the Study:

• To explore the nature and characteristics of bone metastases in hepatocellular carcinoma.
• To elucidate the mechanisms of skeletal colonization in HCC.
• To review current and emerging diagnostic and therapeutic approaches for HCC BMs.

Main Methods:

• Literature review of studies on HCC bone metastases.
• Analysis of factors involved in skeletal colonization, including angiogenesis and epithelial-to-mesenchymal transition.
• Discussion of imaging techniques (CT, bone scintigraphy, PET) and treatment modalities (radiotherapy, local-regional treatments).

Main Results:

• HCC BMs exhibit soft-tissue expansion, high vascularity, and significant tumor burden.
• Osteolytic lesions are common, often detected late by CT and poorly visualized by bone scintigraphy.
• Novel imaging like dual tracer positron emission computerized tomography is under investigation.

Conclusions:

• Angiogenesis and epithelial-to-mesenchymal transition are key factors in HCC skeletal metastasis.
• Advanced imaging techniques are essential for early detection and characterization of HCC BMs.
• Radiotherapy and local-regional treatments offer viable options for managing HCC BMs, considering patient comorbidities like liver failure.